A Case of Organizing Pneumonia Associated with Rituximab.
- Author:
Chi Hoon MAENG
1
;
Sang Ouk CHIN
;
Byung Hyuk YANG
;
Si Young KIM
;
Hwi Joong YOUN
;
Kyung Sam CHO
;
Sun Kyung BAEK
;
Sun LEE
Author Information
1. Department of 1Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea. sykim@khu.ac.kr
- Publication Type:Case Report
- Keywords:
Rituximab;
Organizing pneumonia;
Non-Hodgkin's lymphoma
- MeSH:
B-Lymphocytes;
Chills;
Drug Therapy;
Fever;
Flushing;
Hodgkin Disease;
Humans;
Lymphoma, Non-Hodgkin;
Pneumonia*;
Skin;
Rituximab
- From:Cancer Research and Treatment
2007;39(2):88-91
- CountryRepublic of Korea
- Language:English
-
Abstract:
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible and temporary infusion-related reactions, including fever, chills, flushing and skin reactions, there are several reports of pulmonary events after long-term administration of rituximab. We present a case of asymp-tomatic nodular organizing pneumonia occurring during rituximab-based chemotherapy in a patient with non- Hodgkin's lymphoma.
